Skip to main content
. 2005 Jul 14;106(9):3271–3284. doi: 10.1182/blood-2005-01-0150

Table 1.

Nucleotide sequences change of mtDNA control region from aggregate cells

Donor no. (age, y/sex) and polymorphism Affected genes
Donor no. 1 (48/F)
   73A > G HV2, 7S
   150C > T HV2, 7S, OH
   263A > G HV2, OH
   8CT6C* HV2, OH, CSB2
   16192C > T* HV1, 7S
   16270C > T HV1, 7S
Donor no. 2 (44/M)
   73A > G HV2, 7S
   146T > C HV2, 7S, OH
   152T > C HV2, 7S, OH
   195T > C HV2, OH
   263A > G HV2, OH
   8CT6C,* 9CT6C* HV2, OH, CSB2
   514-515delCA NA
   16223C > T HV1, 7S
   16278C > T HV1, 7S
   16294C > T HV1, 7S
   16390G > A 7S
Donor no. 3 (36/M)
   93A > G HV2, 7S
   95A > C HV2, 7S
   185G > A HV2, 7S, OH
   189A > G HV2, 7S, OH
   236T > C HV2, OH
   8CT6C* HV2, OH, CSB2
   247G > A HV2, OH, TFB1
   263A > G HV2, OH
   514-515delCA NA
   16093T > C HV1
   16129G > A HV1, 7S
   16148C > T HV1, 7S
   16168C > T HV1, 7S, TAS
   16172T > C HV1, 7S, TAS
   16187C > T* HV1, 7S
   16188C > G* HV1, 7S
   16189T > C* HV1, 7S
   16223C > T HV1, 7S
   16230A > G HV1, 7S
   16278C > T HV1, 7S
   16293A > G HV1, 7S
   16311T > C HV1, 7S
   16320C > T HV1, 7S
Donor no. 4 (55/M)
   73A > G HV2, 7S
   263A > G HV2, OH
   7CT6C* HV2, OH, CSB2
   514-515delCA NA
   16126T > C HV1, 7S
   16294C > T HV1, 7S
   16296C > T HV1, 7S
   16519T > C 7S
Donor no. 5 (35/F)
   73A > G HV2, 7S
   150C > T HV2, 7S, OH
   263A > G HV2, OH
   8CT6C* HV2, OH, CSB2
   517A > G NA
   16270C > T HV1, 7S
   16292C > T HV1, 7S
   16362T > C HV1, 7S

HV1 indicates hypervariable segment 1; HV2, hypervariable segment 2; 7S, 7S DNA; OH, H-strand origin; CSB2, conserved sequence block II; TAS, termination-association sequence; TFB1, mitochondrial transcription factor 1 binding site; NA, not applicable.

*

Homopolymeric C tracts at nucleotides 303 to 315 (for example, 7CT6C defined CCCCCCCTCCCCCC) and 16184 to 16193 in HV2 and HV1, respectively

New mtDNA polymorphisms (not listed in MitoMap database)